Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v2.4.0.8
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current Assets    
Total Current Assets      
Total Assets      
Current Liabilities    
Accounts payable and accrued expenses 598,353 466,493
Accounts payable - related party 175,000 175,000
Loan payable - related party 10,000   
Derivative liability 33,662 11,942
Liabilities for discontinued operations 112,397 112,397
Total Current Liabilities 929,412 765,832
Stockholders' Deficit    
Common stock, $0.0001 par value; 200,000,000 shares authorized, 1,510,950 shares issued and outstanding 151 151
Additional paid-in capital 48,382,892 48,203,058
Accumulated deficit (41,947,270) (41,947,270)
Accumulated deficit since inception of exploration stage (April 25, 2011) (7,365,188) (7,021,774)
Total Stockholders' Deficit (929,412) (795,832)
Total Liabilities and Stockholders' Deficit      
Preferred stock, Series B
    
Stockholders' Deficit    
Preferred stock, $0.0001 par value; 20,000,000 shares authorized; Series A, $0.0001 par value; 20,000 shares authorized, 20,000 issued and outstanding; Series B, $0.0001 par value; 30,000 shares authorized, 6,666 issued and outstanding 1 1
Preferred Stock Series A
    
Stockholders' Deficit    
Preferred stock, $0.0001 par value; 20,000,000 shares authorized; Series A, $0.0001 par value; 20,000 shares authorized, 20,000 issued and outstanding; Series B, $0.0001 par value; 30,000 shares authorized, 6,666 issued and outstanding $ 2 $ 2